Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Osmundson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Archives of Internal Medicine|April 1, 1991
Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive?P J Palumbo, W M O'Fallon, P J Osmundson, et al.
Journal of Vascular Surgery|September 1, 1985
Reproducibility of noninvasive tests of peripheral occlusive arterial diseaseP J Osmundson, W M O'Fallon, I P Clements, et al.
Journal of the American College of Cardiology|November 1, 1989
Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: a population-based study, 1971-1987V L Roger, D J Ballard, J W Hallett, et al.
Diabetes Care|February 1, 1990
Course of peripheral occlusive arterial disease in diabetes. Vascular laboratory assessmentP J Osmundson, W M O'Fallon, B R Zimmerman, et al.
Mayo Clinic Proceedings|April 1, 1981
A prospective study of peripheral occlusive arterial disease in diabetes. II. Vascular laboratory assessmentP J Osmundson, J H Chesebro, W M O'Fallon, et al.
Mayo Clinic Proceedings|April 1, 1981
A prospective study of peripheral occlusive arterial disease in diabetes. IV. Platelet and plasma functionsF J Kazmier, E J Bowie, W M O'Fallon, et al.
Mayo Clinic Proceedings|November 1, 1985
Use of captopril as early therapy for renal scleroderma: a prospective studyV L Beckett, J V Donadio, L A Brennan, et al.
Kidney International|November 1, 1990
Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulabilityW J Johnson, J T McCarthy, T Yanagihara, et al.
Mayo Clinic Proceedings|February 1, 1987
Percutaneous transluminal angioplasty in the lower extremities: a 5-year experienceT W Rooke, A W Stanson, C M Johnson, et al.
Arthritis and Rheumatism|October 1, 1984
Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirinV L Beckett, D L Conn, V Fuster, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Archives of Internal Medicine|April 1, 1991
Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive?P J Palumbo, W M O'Fallon, P J Osmundson, et al.
Journal of Vascular Surgery|September 1, 1985
Reproducibility of noninvasive tests of peripheral occlusive arterial diseaseP J Osmundson, W M O'Fallon, I P Clements, et al.
Journal of the American College of Cardiology|November 1, 1989
Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: a population-based study, 1971-1987V L Roger, D J Ballard, J W Hallett, et al.
Diabetes Care|February 1, 1990
Course of peripheral occlusive arterial disease in diabetes. Vascular laboratory assessmentP J Osmundson, W M O'Fallon, B R Zimmerman, et al.
Mayo Clinic Proceedings|April 1, 1981
A prospective study of peripheral occlusive arterial disease in diabetes. II. Vascular laboratory assessmentP J Osmundson, J H Chesebro, W M O'Fallon, et al.
Mayo Clinic Proceedings|April 1, 1981
A prospective study of peripheral occlusive arterial disease in diabetes. IV. Platelet and plasma functionsF J Kazmier, E J Bowie, W M O'Fallon, et al.
Mayo Clinic Proceedings|November 1, 1985
Use of captopril as early therapy for renal scleroderma: a prospective studyV L Beckett, J V Donadio, L A Brennan, et al.
Kidney International|November 1, 1990
Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulabilityW J Johnson, J T McCarthy, T Yanagihara, et al.
Mayo Clinic Proceedings|February 1, 1987
Percutaneous transluminal angioplasty in the lower extremities: a 5-year experienceT W Rooke, A W Stanson, C M Johnson, et al.
Arthritis and Rheumatism|October 1, 1984
Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirinV L Beckett, D L Conn, V Fuster, et al.
Pageof 3